{"id":"https://openalex.org/W2010414720","doi":"https://doi.org/10.1089/adt.2014.605","title":"Bioluminescent Cell-Based NAD(P)/NAD(P)H Assays for Rapid Dinucleotide Measurement and Inhibitor Screening","display_name":"Bioluminescent Cell-Based NAD(P)/NAD(P)H Assays for Rapid Dinucleotide Measurement and Inhibitor Screening","publication_year":2014,"publication_date":"2014-12-01","ids":{"openalex":"https://openalex.org/W2010414720","doi":"https://doi.org/10.1089/adt.2014.605","mag":"2010414720","pmid":"https://pubmed.ncbi.nlm.nih.gov/25506801","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4270152"},"language":"en","primary_location":{"id":"doi:10.1089/adt.2014.605","doi":"https://doi.org/10.1089/adt.2014.605","is_oa":true,"landing_page_url":"https://doi.org/10.1089/adt.2014.605","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1089/adt.2014.605","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091092554","display_name":"Jolanta Vidugirien\u0117","orcid":"https://orcid.org/0009-0008-0334-8500","observed_orcids":["https://orcid.org/0009-0008-0334-8500"]},"institutions":[{"id":"https://openalex.org/I199117387","display_name":"Promega (United States)","ror":"https://ror.org/01dra3713","country_code":"US","type":"company","lineage":["https://openalex.org/I199117387"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jolanta Vidugiriene","raw_affiliation_strings":["Research and Development","Research and Development, Promega Corporation, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development","institution_ids":[]},{"raw_affiliation_string":"Research and Development, Promega Corporation, Madison, Wisconsin","institution_ids":["https://openalex.org/I199117387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023742313","display_name":"Donna Marie Leippe","orcid":"https://orcid.org/0009-0008-3234-914X","observed_orcids":["https://orcid.org/0009-0008-3234-914X"]},"institutions":[{"id":"https://openalex.org/I199117387","display_name":"Promega (United States)","ror":"https://ror.org/01dra3713","country_code":"US","type":"company","lineage":["https://openalex.org/I199117387"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna Leippe","raw_affiliation_strings":["Research and Development","Research and Development, Promega Corporation, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development","institution_ids":[]},{"raw_affiliation_string":"Research and Development, Promega Corporation, Madison, Wisconsin","institution_ids":["https://openalex.org/I199117387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008448473","display_name":"Mary Sobol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I199117387","display_name":"Promega (United States)","ror":"https://ror.org/01dra3713","country_code":"US","type":"company","lineage":["https://openalex.org/I199117387"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary Sobol","raw_affiliation_strings":["Research and Development","Research and Development, Promega Corporation, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development","institution_ids":[]},{"raw_affiliation_string":"Research and Development, Promega Corporation, Madison, Wisconsin","institution_ids":["https://openalex.org/I199117387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110126020","display_name":"Gediminas J. A. Vidugiris","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I199117387","display_name":"Promega (United States)","ror":"https://ror.org/01dra3713","country_code":"US","type":"company","lineage":["https://openalex.org/I199117387"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gediminas Vidugiris","raw_affiliation_strings":["Research and Development","Research and Development, Promega Corporation, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development","institution_ids":[]},{"raw_affiliation_string":"Research and Development, Promega Corporation, Madison, Wisconsin","institution_ids":["https://openalex.org/I199117387"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046821772","display_name":"Wenhui Zhou","orcid":"https://orcid.org/0000-0003-2178-3959","observed_orcids":["https://orcid.org/0000-0003-2178-3959"]},"institutions":[{"id":"https://openalex.org/I199117387","display_name":"Promega (United States)","ror":"https://ror.org/01dra3713","country_code":"US","type":"company","lineage":["https://openalex.org/I199117387"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wenhui Zhou","raw_affiliation_strings":["Promega Biosciences","Promega Biosciences, LLC, San Luis Obispo, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Promega Biosciences","institution_ids":["https://openalex.org/I199117387"]},{"raw_affiliation_string":"Promega Biosciences, LLC, San Luis Obispo, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002485823","display_name":"Poncho L. Meisenheimer","orcid":"https://orcid.org/0000-0003-1918-3153","observed_orcids":["https://orcid.org/0000-0003-1918-3153"]},"institutions":[{"id":"https://openalex.org/I199117387","display_name":"Promega (United States)","ror":"https://ror.org/01dra3713","country_code":"US","type":"company","lineage":["https://openalex.org/I199117387"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Poncho Meisenheimer","raw_affiliation_strings":["Promega Biosciences","Promega Biosciences, LLC, San Luis Obispo, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Promega Biosciences","institution_ids":["https://openalex.org/I199117387"]},{"raw_affiliation_string":"Promega Biosciences, LLC, San Luis Obispo, California","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086139897","display_name":"Prson Gautam","orcid":"https://orcid.org/0000-0002-1154-8501","observed_orcids":["https://orcid.org/0000-0002-1154-8501"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Prson Gautam","raw_affiliation_strings":["University of Helsinki","Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Helsinki","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067760174","display_name":"Krister Wennerberg","orcid":"https://orcid.org/0000-0002-1352-4220","observed_orcids":["https://orcid.org/0000-0002-1352-4220"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I4210133586","display_name":"Institute for Molecular Medicine Finland","ror":"https://ror.org/030sbze61","country_code":"FI","type":"facility","lineage":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Krister Wennerberg","raw_affiliation_strings":["University of Helsinki","Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Helsinki","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I4210133586"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078116014","display_name":"James J. Cali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I199117387","display_name":"Promega (United States)","ror":"https://ror.org/01dra3713","country_code":"US","type":"company","lineage":["https://openalex.org/I199117387"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James J. Cali","raw_affiliation_strings":["Research and Development","Research and Development, Promega Corporation, Madison, Wisconsin"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research and Development","institution_ids":[]},{"raw_affiliation_string":"Research and Development, Promega Corporation, Madison, Wisconsin","institution_ids":["https://openalex.org/I199117387"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5091092554"],"corresponding_institution_ids":["https://openalex.org/I199117387"],"apc_list":null,"apc_paid":null,"fwci":1.0067,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.72699572,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"12","issue":"9-10","first_page":"514","last_page":"526"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12561","display_name":"bioluminescence and chemiluminescence research","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12561","display_name":"bioluminescence and chemiluminescence research","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11051","display_name":"Sirtuins and Resveratrol in Medicine","score":0.04149999842047691,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.011599999852478504,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicotinamide-adenine-dinucleotide","display_name":"NAD+","score":0.7149999737739563},{"id":"https://openalex.org/keywords/nadh","display_name":"NADH","score":0.9810000061988831},{"id":"https://openalex.org/keywords/nadph","display_name":"NADPH","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bioluminescence-assay","display_name":"bioluminescence assay","score":0.7179999947547913},{"id":"https://openalex.org/keywords/cell-based-assays","display_name":"cell-based assays","score":0.6679999828338623},{"id":"https://openalex.org/keywords/inhibitor-screening","display_name":"inhibitor screening","score":0.6740000247955322},{"id":"https://openalex.org/keywords/fk866","display_name":"FK866","score":0.9259999990463257},{"id":"https://openalex.org/keywords/nad-biosynthesis","display_name":"NAD biosynthesis","score":0.8330000042915344},{"id":"https://openalex.org/keywords/entinostat","display_name":"entinostat","score":0.9409999847412109},{"id":"https://openalex.org/keywords/raloxifene","display_name":"raloxifene","score":0.9919999837875366},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8479999899864197},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-modulators","display_name":"selective estrogen receptor modulators","score":0.8629999756813049},{"id":"https://openalex.org/keywords/redox-cofactors","display_name":"redox cofactors","score":0.7440000176429749},{"id":"https://openalex.org/keywords/cell-viability","display_name":"cell viability","score":0.6209999918937683}],"concepts":[{"id":"https://openalex.org/C75520062","wikidata":"https://www.wikidata.org/wiki/Q15321392","display_name":"NAD+ kinase","level":3,"score":0.9386118650436401},{"id":"https://openalex.org/C2776901170","wikidata":"https://www.wikidata.org/wiki/Q12499775","display_name":"Nicotinamide adenine dinucleotide","level":4,"score":0.8282166719436646},{"id":"https://openalex.org/C197957613","wikidata":"https://www.wikidata.org/wiki/Q407280","display_name":"Cofactor","level":3,"score":0.605570375919342},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5667558312416077},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.5601828694343567},{"id":"https://openalex.org/C2779728014","wikidata":"https://www.wikidata.org/wiki/Q192423","display_name":"Nicotinamide","level":3,"score":0.5372298955917358},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5028232932090759},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.4537014663219452},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.3941196799278259},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3623947501182556},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3277361989021301},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2040877342224121}],"mesh":[{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D000178","descriptor_name":"Acrylamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008163","descriptor_name":"Luminescent Measurements","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008163","descriptor_name":"Luminescent Measurements","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":false},{"descriptor_ui":"D009249","descriptor_name":"NADP","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D009249","descriptor_name":"NADP","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D010084","descriptor_name":"Oxidation-Reduction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019169","descriptor_name":"Jurkat Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056945","descriptor_name":"Hep G2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1089/adt.2014.605","doi":"https://doi.org/10.1089/adt.2014.605","is_oa":true,"landing_page_url":"https://doi.org/10.1089/adt.2014.605","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3240431","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4270152","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4270152","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4270152","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Assay Drug Dev Technol","raw_type":"Text"},{"id":"pmid:25506801","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25506801","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Assay and drug development technologies","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1089/adt.2014.605","doi":"https://doi.org/10.1089/adt.2014.605","is_oa":true,"landing_page_url":"https://doi.org/10.1089/adt.2014.605","pdf_url":null,"source":{"id":"https://openalex.org/S76283439","display_name":"Assay and Drug Development Technologies","issn_l":"1540-658X","issn":["1540-658X","1557-8127"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ASSAY and Drug Development Technologies","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322282","display_name":"Jane ja Aatos Erkon S\u00e4\u00e4ti\u00f6","ror":"https://ror.org/03vxy9y38"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W179735311","https://openalex.org/W1970554352","https://openalex.org/W1973540113","https://openalex.org/W1981106431","https://openalex.org/W1991001144","https://openalex.org/W2002783575","https://openalex.org/W2005184259","https://openalex.org/W2012538520","https://openalex.org/W2014880757","https://openalex.org/W2028897202","https://openalex.org/W2030955780","https://openalex.org/W2031050244","https://openalex.org/W2047503781","https://openalex.org/W2053168686","https://openalex.org/W2061440283","https://openalex.org/W2063556241","https://openalex.org/W2078448804","https://openalex.org/W2078851955","https://openalex.org/W2080239208","https://openalex.org/W2080863876","https://openalex.org/W2082548175","https://openalex.org/W2089838011","https://openalex.org/W2091385281","https://openalex.org/W2092395372","https://openalex.org/W2092950801","https://openalex.org/W2099613995","https://openalex.org/W2111614709","https://openalex.org/W2112523400","https://openalex.org/W2113375900","https://openalex.org/W2115298350","https://openalex.org/W2115517051","https://openalex.org/W2125997801","https://openalex.org/W2135174215","https://openalex.org/W2138382181","https://openalex.org/W2146738245","https://openalex.org/W2155184340","https://openalex.org/W2158989541","https://openalex.org/W2161809910","https://openalex.org/W2168177588","https://openalex.org/W2285808960"],"related_works":["https://openalex.org/W1979010038","https://openalex.org/W2323596507","https://openalex.org/W2046416590","https://openalex.org/W2056141286","https://openalex.org/W1992459118","https://openalex.org/W2063556241","https://openalex.org/W6893671066","https://openalex.org/W4317506511","https://openalex.org/W1972544099","https://openalex.org/W2805522187"],"abstract_inverted_index":{"Abstract":[0],"The":[1,81,101,129,191],"central":[2],"role":[3],"of":[4,23,38,47,57,61,69,72,84,193,199,232],"nicotinamide":[5,201,234,251],"adenine":[6,202,235,252],"dinucleotides":[7,76],"in":[8,78,92,186,249],"cellular":[9,233,250],"energy":[10,26],"metabolism":[11],"and":[12,28,44,121,136],"signaling":[13],"makes":[14],"them":[15],"important":[16,49],"nodes":[17],"that":[18,54,173],"link":[19],"the":[20,36,55,58,66,110,137,153,160,194,223,238],"metabolic":[21],"state":[22],"cells":[24],"with":[25,109,152,164],"homeostasis":[27],"gene":[29],"regulation.":[30],"In":[31],"this":[32],"study,":[33],"we":[34,171],"describe":[35],"implementation":[37],"cell-based":[39],"bioluminescence":[40],"assays":[41,59,130,163,195],"for":[42,119,126],"rapid":[43],"sensitive":[45],"measurement":[46],"those":[48],"redox":[50],"cofactors.":[51],"We":[52],"show":[53,172],"sensitivity":[56],"(limit":[60],"detection":[62,68,162],"\u223c0.5":[63],"nM)":[64],"enables":[65],"selective":[67,239],"total":[70,82],"amounts":[71],"nonphosphorylated":[73],"or":[74,86,97],"phosphorylated":[75],"directly":[77],"cell":[79,168,187],"lysates.":[80],"amount":[83],"NAD+NADH":[85,120],"NADP+NADPH":[87,127],"levels":[88,175,204],"can":[89,176],"be":[90,177],"detected":[91],"as":[93,95],"low":[94],"300":[96],"600":[98],"cells/well,":[99],"respectively.":[100],"signal":[102],"remains":[103],"linear":[104],"up":[105],"to":[106,117,124,196],"5,000":[107],"cells/well":[108],"maximum":[111],"signal-to-background":[112],"ratios":[113],"ranging":[114],"from":[115,122],"100":[116,125],"200":[118],"50":[123],"detection.":[128],"are":[131,189],"robust":[132],"(Z'":[133],"value":[134],">0.7)":[135],"inhibitor":[138,148,226,231],"response":[139],"curves":[140],"generated":[141],"using":[142,208],"a":[143,165,229,246],"known":[144],"NAD":[145],"biosynthetic":[146],"pathway":[147],"FK866":[149,182],"correlate":[150],"well":[151],"reported":[154],"data.":[155],"More":[156],"importantly,":[157],"by":[158,181],"multiplexing":[159],"dinucleotide":[161,174,203,216,253],"fluorescent":[166],"nonmetabolic":[167],"viability":[169,188],"assay,":[170],"decreased":[178],"dramatically":[179],"(>80%)":[180],"treatment":[183],"before":[184],"changes":[185],"detected.":[190],"utility":[192],"identify":[197],"modulators":[198],"intracellular":[200],"was":[205,228],"further":[206],"confirmed":[207],"an":[209],"oncology":[210],"active":[211],"compound":[212],"library,":[213],"where":[214],"novel":[215],"regulating":[217],"compounds":[218],"were":[219],"identified.":[220],"For":[221],"example,":[222],"histone":[224],"deacetylase":[225],"entinostat":[227],"potent":[230],"dinucleotides,":[236],"whereas":[237],"estrogen":[240],"receptor":[241],"modulator":[242],"raloxifene":[243],"unexpectedly":[244],"caused":[245],"twofold":[247],"increase":[248],"levels.":[254]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}